Literature DB >> 17876298

Endothelial cells of human colorectal cancer and healthy colon reveal phenotypic differences in culture.

Vera Simone Schellerer1, Roland Siegfried Croner, Kristina Weinländer, Werner Hohenberger, Michael Stürzl, Elisabeth Naschberger.   

Abstract

Antiangiogenic drugs have been used successfully for the treatment of colorectal cancer (CRC). Viable tumor endothelial cells (TEC) and normal endothelial cells (NEC) of uninvolved colon tissue of the same patient have not been available to optimize treatment strategies in vitro. Therefore, our target was to establish a protocol for the isolation of TEC and NEC. These cells were isolated with very high purity via magnetic cell sorting of tissue samples obtained from CRC and healthy colon of eight patients. TEC and NEC expressed CD31, CD105, VE-cadherin, VCAM-1, ICAM-1 and E-selectin, formed capillaries in basal membrane extract and were able to take up acetylated low-density lipoprotein. They were negative for podoplanin, CD45, CD68 and cytokeratin-20 indicating blood vessel endothelial lineage. Intense staining of von Willebrand factor (vWF) was observed in five of eight NEC cultures, whereas vWF was absent or only slightly expressed in all TEC cultures in vitro. Low intracellular concentration of vWF was also detected in TEC and NEC at the tissue level. This demonstrated that differences exhibited by TEC and NEC in vivo are stably perpetuated in culture. The isolated cultures may provide a useful in vitro model to elucidate epigenetic effects on angiogenesis in cancer and to optimize antiangiogenic therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876298     DOI: 10.1038/labinvest.3700671

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  HUIEC, Human intestinal epithelial cell line with differentiated properties: process of isolation and characterisation.

Authors:  Lidija Gradisnik; Martin Trapecar; Marjan Slak Rupnik; Tomaz Velnar
Journal:  Wien Klin Wochenschr       Date:  2015-03-28       Impact factor: 1.704

Review 2.  Tumor endothelial cells.

Authors:  Andrew C Dudley
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

Review 3.  Physiological and pathological role of local and immigrating colonic stem cells.

Authors:  Ferenc Sipos; Gábor Valcz; Béla Molnár
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

4.  Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol.

Authors:  Elisabeth Naschberger; Daniela Regensburger; Clara Tenkerian; Melanie Langheinrich; Felix B Engel; Carol Geppert; Arndt Hartmann; Robert Grützmann; Vera S Schellerer; Michael Stürzl
Journal:  J Vis Exp       Date:  2018-04-04       Impact factor: 1.355

5.  Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma.

Authors:  Elisabeth Naschberger; Andrea Liebl; Vera S Schellerer; Manuela Schütz; Nathalie Britzen-Laurent; Patrick Kölbel; Ute Schaal; Lisa Haep; Daniela Regensburger; Thomas Wittmann; Ludger Klein-Hitpass; Tilman T Rau; Barbara Dietel; Valérie S Méniel; Alan R Clarke; Susanne Merkel; Roland S Croner; Werner Hohenberger; Michael Stürzl
Journal:  J Clin Invest       Date:  2016-10-10       Impact factor: 14.808

6.  Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.

Authors:  Mathias Thurau; Gaby Marquardt; Nathalie Gonin-Laurent; Kristina Weinländer; Elisabeth Naschberger; Ramona Jochmann; Khaled R Alkharsah; Thomas F Schulz; Margot Thome; Frank Neipel; Michael Stürzl
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

7.  Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells.

Authors:  Yan Xu; Dan Wang; Li-Mei Zhao; Xi-Long Zhao; Jun-Jie Shen; Yao Xie; Li-Li Cao; Zhen-Bo Chen; Yan-Mei Luo; Bi-Hui Bao; Zhi-Qing Liang
Journal:  Cancer Biol Ther       Date:  2013-08-05       Impact factor: 4.742

8.  Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases.

Authors:  Matthias Hammon; Martin Herrmann; Oliver Bleiziffer; Galyna Pryymachuk; Laura Andreoli; Luis E Munoz; Kerstin U Amann; Michele Mondini; Marisa Gariglio; Paolo Airó; Vera S Schellerer; Antonis K Hatzopoulos; Raymund E Horch; Ulrich Kneser; Michael Stürzl; Elisabeth Naschberger
Journal:  J Cell Mol Med       Date:  2011-07       Impact factor: 5.310

9.  Specific extracellular matrix remodeling signature of colon hepatic metastases.

Authors:  Maguy Del Rio; Caroline Mollevi; Nadia Vezzio-Vie; Frédéric Bibeau; Marc Ychou; Pierre Martineau
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study.

Authors:  Luigia Rao; Kim De Veirman; Donato Giannico; Ilaria Saltarella; Vanessa Desantis; Maria Antonia Frassanito; Antonio Giovanni Solimando; Domenico Ribatti; Marcella Prete; Andreas Harstrick; Ulrike Fiedler; Hendrik De Raeve; Vito Racanelli; Karin Vanderkerken; Angelo Vacca
Journal:  Oncotarget       Date:  2018-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.